fda bpc-157 warning letter unapproved peptide to weigh easing limits on unproven peptides favored by RFK Jr As interest in weight loss

B12 injections may benefit individuals experiencing fatigue, cognitive decline, or symptoms of B12 deficiency

Los sntomas asociados con la vitamina B12 pueden enmascarar los signos de policitemia vera

This allows procurement teams to focus on research objectives rather than inventory concerns

Peterson, N

Supports Weight Loss Efforts: B12 injections are often associated with weight loss due to their potential to boost metabolism and energy levels

In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday